Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
Clin Res Hepatol Gastroenterol
    July 2021
  1. LANTHIER N, Starkel P, Dahlqvist G
    Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity?
    Clin Res Hepatol Gastroenterol. 2021;45:101721.
    >> Share

    May 2021
  2. VUJAKLIJA BRAJKOVIC A, Zlopasa O, Gubarev Vrdoljak N, Goran T, et al
    Acute liver and cardiac failure in multisystem inflammatory syndrome in adults after COVID-19.
    Clin Res Hepatol Gastroenterol. 2021;45:101678.
    >> Share

  3. SERRA F, Bonaduce I, De Ruvo N, Cautero N, et al
    Covid-19 and hepatic injury: A systematic review.
    Clin Res Hepatol Gastroenterol. 2021;45:101605.
    >> Share

  4. SHIHA G, Soliman R, Mikhail N, Zaky S, et al
    HCC developed in CHC patients who achieved SVR following DAAs tend to display less aggressive pattern.
    Clin Res Hepatol Gastroenterol. 2021;45:101608.
    >> Share

    November 2020
  5. BEST MG, Wurdinger T
    Tumor-educated platelets for the earlier detection of hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2020;44:794-795.
    >> Share

    October 2020
  6. WANG H, Qiu P, Liu J, Wang F, et al
    The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2020;44:653-661.
    >> Share

  7. RAHAL HK, Tabibian JH
    The MBOAT7 rs641738 variant in primary sclerosing cholangitis: A novel biomarker for prognostication.
    Clin Res Hepatol Gastroenterol. 2020;44:619-621.
    >> Share

    September 2020
  8. ALI N
    Is SARS-CoV-2 associated with liver dysfunction in COVID-19 patients?
    Clin Res Hepatol Gastroenterol. 2020;44:e84-e86.
    >> Share

    June 2020
  9. DE GOTTARDI A, Fratila C, Bertoli R, Cerny A, et al
    Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection.
    Clin Res Hepatol Gastroenterol. 2020 Jun 10. pii: S2210-7401(20)30159.
    >> Share

  10. GANNE-CARRIE N, Fontaine H, Dumortier J, Boursier J, et al
    Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic.
    Clin Res Hepatol Gastroenterol. 2020;44:275-281.
    >> Share

    January 2020
  11. HEDJOUDJE A, Cervoni JP, Patry C, Chatot M, et al
    Takotsubo cardiomyopathy triggered by delirium tremens in a cirrhotic patient with acute-on-chronic liver failure: A case report.
    Clin Res Hepatol Gastroenterol. 2020 Jan 9. pii: S2210-7401(19)30262.
    >> Share

    December 2019
  12. GOUMARD C, Scatton O
    Resectable HCC: Should salvage liver transplantation for HCC be discussed de principe?
    Clin Res Hepatol Gastroenterol. 2019 Dec 18. pii: S2210-7401(19)30251.
    >> Share

    November 2019
  13. ALLAIRE M, Cadranel JF, Nguyen TTN, Garioud A, et al
    Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.
    Clin Res Hepatol Gastroenterol. 2019 Nov 6. pii: S2210-7401(19)30224.
    >> Share

    October 2019
  14. ALLAIRE M, Walter A, Sutter O, Nahon P, et al
    TIPS for management of portal-hypertension-related complications in patients with cirrhosis.
    Clin Res Hepatol Gastroenterol. 2019 Oct 26. pii: S2210-7401(19)30217.
    >> Share

    August 2019
  15. WANLESS IR
    Quantitative SHG-microscopy: Unraveling the nano-architecture of the cirrhotic liver.
    Clin Res Hepatol Gastroenterol. 2019 Aug 12. pii: S2210-7401(19)30174.
    >> Share

    June 2019
  16. LIBERAL R, Gaspar R, Lopes S, Macedo G, et al
    Primary biliary cholangitis in patients with inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2019 Jun 3. pii: S2210-7401(19)30099.
    >> Share

    April 2019
  17. SCHIELKE A, Scatton O, Boelle PY, Perdigao F, et al
    Ischemic-type biliary lesions: A leading indication of liver retransplantation with excellent results.
    Clin Res Hepatol Gastroenterol. 2019;43:131-139.
    >> Share

  18. MURATORI P, Lenzi M, Muratori L
    Diagnosis of primary biliary cholangitis in a "teen" male patient.
    Clin Res Hepatol Gastroenterol. 2019;43:e20-e21.
    >> Share

    March 2019
  19. YANG F, Ren H, Gao Y, Zhu Y, et al
    The value of severe vitamin D deficiency in predicting the mortality risk of patients with liver cirrhosis: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2019 Mar 29. pii: S2210-7401(19)30052.
    >> Share

  20. MAESTAS C, Lazkani M, Sultan M, Kolli G, et al
    Severe takotsubo cardiomyopathy following orthotopic liver transplantation: A case series.
    Clin Res Hepatol Gastroenterol. 2019 Mar 7. pii: S2210-7401(18)30266.
    >> Share

  21. QU W, Zhu ZJ, Wei L, Sun LY, et al
    Feasibility of domino liver transplantation from hyperhomocsyteinemia.
    Clin Res Hepatol Gastroenterol. 2019 Mar 7. pii: S2210-7401(19)30039.
    >> Share

    February 2019
  22. POUJOIS A, Woimant F
    Answer to challenging issues in the management of Wilson's disease.
    Clin Res Hepatol Gastroenterol. 2019;43:e7-e8.
    >> Share

  23. GUILLAUD O, Dumortier J, Traclet J, Restier L, et al
    Assessment of liver fibrosis by transient elastography (Fibroscan((R))) in patients with A1AT deficiency.
    Clin Res Hepatol Gastroenterol. 2019;43:77-81.
    >> Share

  24. YU C, Wang L, Xue H, Lin H, et al
    Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes.
    Clin Res Hepatol Gastroenterol. 2019;43:58-66.
    >> Share

  25. BAKER A, Kerkar N, Todorova L, Kamath BM, et al
    Systematic review of progressive familial intrahepatic cholestasis.
    Clin Res Hepatol Gastroenterol. 2019;43:20-36.
    >> Share

  26. LEONI MC, Amelung L, Lieveld FI, van den Brink J, et al
    Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease.
    Clin Res Hepatol Gastroenterol. 2019;43:37-44.
    >> Share

  27. BIOULAC-SAGE P, Sempoux C, Frulio N, Le Bail B, et al
    Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes.
    Clin Res Hepatol Gastroenterol. 2019;43:12-19.
    >> Share

  28. CASTRO NARRO GE, Consuelo Sanchez A, Salazar Martinez A, Gamboa Dominguez A, et al
    The silent course of liver steatosis and fibrosis in an adult patient with Cholesteryl Ester Storage Disease.
    Clin Res Hepatol Gastroenterol. 2019;43:e4-e6.
    >> Share

  29. LOESCH R, Desbois-Mouthon C, Colnot S
    Potentials of CRISPR in liver research and therapy.
    Clin Res Hepatol Gastroenterol. 2019;43:5-11.
    >> Share

    January 2019
  30. LEBRAY P, Varnous S
    Combined heart and liver transplantation: State of knowledge and outlooks.
    Clin Res Hepatol Gastroenterol. 2019 Jan 8. pii: S2210-7401(18)30173.
    >> Share

    December 2018
  31. BERGERE M, Erard-Poinsot D, Boillot O, Valette PJ, et al
    Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Clin Res Hepatol Gastroenterol. 2018 Dec 18. pii: S2210-7401(18)30268.
    >> Share

  32. LANKARANI KB
    Challenging issues in the management of Wilson's disease.
    Clin Res Hepatol Gastroenterol. 2018;42:e95-e96.
    >> Share

    October 2018
  33. RAMADAN HK, Makhlouf NA, Mahmoud AA, Abd Elrhman M, et al
    Role of vitamin D deficiency as a risk factor for infections in cirrhotic patients.
    Clin Res Hepatol Gastroenterol. 2018 Oct 11. pii: S2210-7401(18)30182.
    >> Share

  34. LE BAIL B, Chiche L, Balabaud C, Bioulac-Sage P, et al
    Collision of hepatocellular nodules in vascular livers: A medical challenge.
    Clin Res Hepatol Gastroenterol. 2018;42:e83-e85.
    >> Share

    August 2018
  35. WANG C, Huang Z, Huang X, Liu C, et al
    Surgical outcomes between patients with and without a cirrhotic liver undergoing laparoscopic liver resection: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2018 Aug 10. pii: S2210-7401(18)30120.
    >> Share

    May 2018
  36. DUMORTIER J, Maucort-Boulch D, Poinsot D, Thimonier E, et al
    Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease.
    Clin Res Hepatol Gastroenterol. 2018 May 31. pii: S2210-7401(18)30087.
    >> Share

  37. PINERO F, Costa P, Boteon YL, Duque SH, et al
    A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America.
    Clin Res Hepatol Gastroenterol. 2018 May 14. pii: S2210-7401(18)30074.
    >> Share

    March 2018
  38. BIHARI C, Patil A, Sarin SK
    Adequate platelet counts in cirrhosis for laboratory-based optimum platelet functions.
    Clin Res Hepatol Gastroenterol. 2018 Mar 31. pii: S2210-7401(18)30044.
    >> Share

  39. SUH SW, Choi YS, Hong SA, Kang H, et al
    Preoperative erythropoietin treatment improves survival following major hepatic resection in a cirrhotic rat model.
    Clin Res Hepatol Gastroenterol. 2018 Mar 23. pii: S2210-7401(17)30268.
    >> Share

  40. HUNG TH, Lee HF, Tseng CW, Tsai CC, et al
    Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding.
    Clin Res Hepatol Gastroenterol. 2018 Mar 15. pii: S2210-7401(17)30267.
    >> Share

  41. MALLET M, Weiss N, Thabut D, Rudler M, et al
    Why and when to measure ammonemia in cirrhosis?
    Clin Res Hepatol Gastroenterol. 2018 Mar 15. pii: S2210-7401(18)30031.
    >> Share

    February 2018
  42. BENHAMED F, Postic C
    A new pathway to eSCAPe lipotoxicity.
    Clin Res Hepatol Gastroenterol. 2018;42:3-5.
    >> Share

    December 2017
  43. PERNOT S, Velut G, Kourie RH, Amouyal G, et al
    5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases.
    Clin Res Hepatol Gastroenterol. 2017 Dec 7. pii: S2210-7401(17)30260.
    >> Share

  44. SANG W, Lv B, Li K, Lu Y, et al
    Therapeutic efficacy and safety of umbilical cord mesenchymal stem cell transplantation for liver cirrhosis in Chinese population: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Dec 6. pii: S2210-7401(17)30259.
    >> Share

    November 2017
  45. BRUSTIA R, Savier E, Scatton O
    Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Nov 18. pii: S2210-7401(17)30214.
    >> Share

    October 2017
  46. ZHANG CH, Zheng L, Gui L, Lin JY, et al
    Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats.
    Clin Res Hepatol Gastroenterol. 2017 Oct 11. pii: S2210-7401(17)30187.
    >> Share

  47. LEMOINNE S, Marteau P
    Gut microbial profile in primary biliary cholangitis: Towards bioindicators.
    Clin Res Hepatol Gastroenterol. 2017;41:507-508.
    >> Share

    September 2017
  48. MURATORI P, Muratori L
    Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2017;41:e47.
    >> Share

    August 2017
  49. MA X, Sun D, Li C, Ying J, et al
    Statin use and virus-related cirrhosis: A systemic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Aug 30. pii: S2210-7401(17)30180.
    >> Share

    April 2017
  50. TRAN MINH M, Mazzola A, Perdigao F, Charlotte F, et al
    Primary hepatic angiosarcoma and liver transplantation: Radiological, surgical, histological findings and clinical outcome.
    Clin Res Hepatol Gastroenterol. 2017 Apr 14. pii: S2210-7401(17)30077.
    >> Share

  51. SAXENA P, Bihari C, Mirza R, Bhadoria AS, et al
    Exogenous growth factor based regenerative therapy in alcoholic cirrhosis patients renders limited effect on hemostatic elements.
    Clin Res Hepatol Gastroenterol. 2017 Apr 12. pii: S2210-7401(17)30080.
    >> Share

    March 2017
  52. JAMSHIDZADEH A, Heidari R, Latifpour Z, Ommati MM, et al
    Carnosine ameliorates liver fibrosis and hyperammonemia in cirrhotic rats.
    Clin Res Hepatol Gastroenterol. 2017 Mar 7. pii: S2210-7401(17)30009.
    >> Share

  53. CHEN Y, Li L, Qian X, Ge Y, et al
    High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2017;41:190-196.
    >> Share

  54. BAO S, Zheng J, Li N, Huang C, et al
    Role of interleukin-23 in monocyte-derived dendritic cells of HBV-related acute-on-chronic liver failure and its correlation with the severity of liver damage.
    Clin Res Hepatol Gastroenterol. 2017;41:147-155.
    >> Share

  55. KANG HG, Wang BZ, Zhang J, Liu MR, et al
    Combination of temsirolimus and adriamycin exhibits an enhanced antitumor effect in hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2017;41:197-203.
    >> Share

  56. HUANG R, Zhang Q, Huang Q, Zu M, et al
    Number and function of circulating endothelial progenitor cells in patients with primary Budd-Chiari syndrome.
    Clin Res Hepatol Gastroenterol. 2017;41:139-146.
    >> Share

  57. MA W, Wang H, Jing W, Zhou F, et al
    Downregulation of long non-coding RNAs JPX and XIST is associated with the prognosis of hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2017;41:163-170.
    >> Share

    February 2017
  58. LI K, Liu H, Guo T
    Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients.
    Clin Res Hepatol Gastroenterol. 2017 Feb 3. pii: S2210-7401(17)30003.
    >> Share

  59. MOTAMED N, Rabiee B, Poustchi H, Dehestani B, et al
    Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
    Clin Res Hepatol Gastroenterol. 2017;41:31-38.
    >> Share

  60. SHIN JH, Jung JH
    Non-alcoholic fatty liver disease and flavonoids: Current perspectives.
    Clin Res Hepatol Gastroenterol. 2017;41:17-24.
    >> Share

  61. MANENTI A, Roncati L, Simonini E, Farinetti A, et al
    HCC chemoembolization: Still a challenge.
    Clin Res Hepatol Gastroenterol. 2017;41:e14-e16.
    >> Share

  62. TAS A, Kara B, Yilmaz C, Suat Yalcin M, et al
    Fulminant Budd-Chiari syndrome due to ecstasy.
    Clin Res Hepatol Gastroenterol. 2017;41:e12-e13.
    >> Share

  63. CHEN P, Yuan P, Chen B, Sun J, et al
    Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017;41:75-85.
    >> Share

  64. WATSON A, Bul V, Staudacher J, Carroll R, et al
    The predictors of mortality and secular changes in management strategies in emphysematous gastritis.
    Clin Res Hepatol Gastroenterol. 2017;41:e1-e7.
    >> Share

    December 2016
  65. ZHENG L, Qin J, Sun L, Gui L, et al
    Intrahepatic upregulation of MRTF-A signaling contributes to increased hepatic vascular resistance in cirrhotic rats with portal hypertension.
    Clin Res Hepatol Gastroenterol. 2016 Dec 30. pii: S2210-7401(16)30203.
    >> Share

    November 2016
  66. XU SL, Zhang YC, Wang GY, Yang Q, et al
    Survival analysis of sirolimus-based immunosuppression in liver transplantation in patients with hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2016 Nov 4. pii: S2210-7401(16)30046.
    >> Share

    July 2016
  67. TAS A, Olmez S, Yalcin MS
    A rare cause of elevated alpha fetoprotein in patient with cirrhosis.
    Clin Res Hepatol Gastroenterol. 2016 Jul 5. pii: S2210-7401(16)30084.
    >> Share

    May 2016
  68. WOSIEWICZ P, Zorniak M, Hartleb M, Baranski K, et al
    Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability.
    Clin Res Hepatol Gastroenterol. 2016 May 5. pii: S2210-7401(16)30048.
    >> Share

    April 2016
  69. LIU L, Zhang C, Hu Y, Zhou L, et al
    Changes in gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation.
    Clin Res Hepatol Gastroenterol. 2016 Apr 6. pii: S2210-7401(16)30038.
    >> Share

    February 2016
  70. ISMAIL H, Broniszczak D, Markiewicz-Kijewska M, Ciopinski M, et al
    Metastases of pancreatic neuroendocrine tumor to the liver as extremely rare indication for liver transplantation in children. Case report and review of the literature.
    Clin Res Hepatol Gastroenterol. 2016 Feb 2. pii: S2210-7401(15)00292.
    >> Share

    November 2015
  71. RASZEJA-WYSZOMIRSKA J, Wunsch E, Krawczyk M, Rigopoulou EI, et al
    Assessment of health related quality of life in polish patients with primary biliary cirrhosis.
    Clin Res Hepatol Gastroenterol. 2015 Nov 24. pii: S2210-7401(15)00260.
    >> Share

    October 2015
  72. GAO PJ, Gao J, Li Z, Hu ZP, et al
    Liver transplantation in adults with portal vein thrombosis: Data from the China Liver Transplant Registry.
    Clin Res Hepatol Gastroenterol. 2015 Oct 20. pii: S2210-7401(15)00121.
    >> Share

    September 2015
  73. HU Z, Qian Z, Wu J, Zhou J, et al
    Clinical outcomes and risk factors of hepatocellular carcinoma treated by liver transplantation: A multi-centre comparison of living donor and deceased donor transplantation.
    Clin Res Hepatol Gastroenterol. 2015 Sep 14. pii: S2210-7401(15)00208.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016